Invesco S&P MidCap 400® Pure Growth ETF holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
Invesco S&P MidCap 400® Pure Growth ETF RFG
Morningstar’s Analysis RFG
Will RFG outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Halozyme Therapeutics Inc | 3.41 | 11M | Healthcare |
TechnipFMC PLC | 2.28 | 7M | Energy |
Valaris Ltd | 2.21 | 7M | Energy |
Medpace Holdings Inc | 2.21 | 7M | Healthcare |
InterDigital Inc | 1.97 | 6M | Technology |
Arrowhead Pharmaceuticals Inc | 1.84 | 6M | Healthcare |
Five Below Inc | 1.83 | 6M | Consumer Cyclical |
DigitalOcean Holdings Inc | 1.81 | 6M | Technology |
Exelixis Inc | 1.75 | 6M | Healthcare |
Woodward Inc | 1.63 | 5M | Industrials |